Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05949580 · ClinicalTrials.gov registry record
Study to Evaluate the Usability and Value of Integrated Digital Solutions in Medical Care of Participants With Multiple Sclerosis
A clinical trial of Relapsing Remitting Multiple Sclerosis, sponsored by Hoffmann-La Roche.
- Recruiting
- Registry status
- 500
- Enrollment target
- 5
- Study locations
NCT05949580 is a study of Relapsing Remitting Multiple Sclerosis that is actively recruiting participants, run by Hoffmann-La Roche. The registered enrollment target is 500 participants, above the 183-participant average among 25 other Relapsing Remitting Multiple Sclerosis trials with a reported enrollment target (173% higher). The trial reports 5 study locations across 3 states.
The verdict
NCT05949580, a study of Relapsing Remitting Multiple Sclerosis, is actively recruiting participants, sponsored by Hoffmann-La Roche.
- RECRUITING
- Registry status
- 500 participants
- Enrollment target
- 5
- Study locations
Study Summary
The main purpose of this study is to assess the usability and value of the multiple sclerosis (MS) care management platform in terms of improved monitoring of people with MS (pwMS) in clinical practice. This is a two-year prospective data collection study with additional data collection at baseline evaluating medical practice over a period of at least one year before the introduction of the MS care management platform.
Conditions Studied
Interventions
- DEVICE MS Care Platform (icobrain ms and icompanion ms)
Study Locations (5)
New Jersey
- Hackensack University Medical Center - Hackensack
- Jersey Shore University Medical Centre - Neptune City
Other
- Universitaetsklinikum Carl Gustav Carus an der TU Dresden - Dresden
- Praxis Dr. med. Max Deist und Michael Ernst ?Sinsheim - Sinsheim
Minnesota
- Minneapolis Clinic of Neurology - Golden Valley
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 500 participants |
| Start Date | 2024-10-21 |
| Est. Completion | 2028-03-31 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT05949580
The ClinicalTrials.gov registry entry for NCT05949580 describes a study currently listed as recruiting, categorized as an unspecified phase. The registered enrollment target is 500 participants, a figure that helps gauge the scale of data the investigators plan to collect, above the 183-participant average among 25 other Relapsing Remitting Multiple Sclerosis trials with a reported enrollment target (173% higher). The listed sponsor is Hoffmann-La Roche, which has 909 total studies on file at ClinicalTrials.gov.
The record links to 1 condition, with Relapsing Remitting Multiple Sclerosis appearing as the primary indexed condition, and to 1 intervention - of which MS Care Platform (icobrain ms and icompanion ms) is the first listed.
NCT05949580 reports 5 study locations spanning 3 distinct geographic areas - top geographies include New Jersey, Other, Minnesota.
Frequently Asked Questions
What is clinical trial NCT05949580 about?
NCT05949580 is a clinical study titled "Study to Evaluate the Usability and Value of Integrated Digital Solutions in Medical Care of Participants With Multiple Sclerosis". The main purpose of this study is to assess the usability and value of the multiple sclerosis (MS) care management platform in terms of improved monitoring of people with MS (pwMS) in clinical practice. This is a two-year prospective data collection study with additional data collection at baseline...
What is the current status of trial NCT05949580?
This trial is currently recruiting. The enrollment target is 500 participants. The study started on 2024-10-21. Estimated completion is 2028-03-31.
What conditions does trial NCT05949580 study?
This clinical trial studies the following conditions: Relapsing Remitting Multiple Sclerosis.
What interventions are being tested in trial NCT05949580?
The interventions under investigation include: MS Care Platform (icobrain ms and icompanion ms) (DEVICE).
Who is sponsoring clinical trial NCT05949580?
This trial is sponsored by Hoffmann-La Roche, which has 909 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT05949580 being conducted?
This trial has 5 study locations across Minnesota, New Jersey. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Relapsing Remitting Multiple Sclerosis
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Exploratory Study on the Timing of Multiple Sclerosis (MS) Symptoms
RECRUITING
-
The SetPoint System as a Pro-Remyelination Therapy for Relapsing-Remitting Multiple Sclerosis: A Pilot Study
RECRUITING · NA
-
Functional Outcomes From Diets in Multiple Sclerosis
RECRUITING · NA
-
Best Available Therapy Versus Autologous Hematopoietic Stem Cell Transplant for Multiple Sclerosis (BEAT-MS)
RECRUITING · Phase 3
-
Clinically Isolated Syndrome and Relapsing-Remitting Multiple Sclerosis
ACTIVE NOT RECRUITING · NA
-
Reduced Oligodendrocyte-specific Cytotoxicity and Ofatumumab Treatment
ACTIVE NOT RECRUITING
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.